{"id":"W2096764404","doi":"10.1093/annonc/mdq626","title":"An international phase II trial of single-agent lenalidomide for relapsed or refractory aggressive B-cell non-Hodgkin’s lymphoma","year":2011,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":393,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Celgene","keywords":"Medicine; Lenalidomide; Refractory (planetary science); Lymphoma; Aggressive lymphoma; Oncology; Internal medicine; Multiple myeloma; Rituximab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001809052,0.00158446,0.002361092,0.0005018883,0.0004899522,0.001177387,0.001346766,0.001155602,0.003544437],"category_scores_gemma":[0.000829206,0.0005047036,0.001441994,0.0004338248,0.001461553,0.001168525,0.000617672,0.00418921,0.001083996],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00139639,"about_ca_system_score_gemma":0.00149567,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001408316,"about_ca_topic_score_gemma":0.004400677,"domain_scores_codex":[0.9994621,0.0002709442,0.0000267064,0.00008808619,0.00004024781,0.0001119953],"domain_scores_gemma":[0.9993174,0.0001060188,0.00007509005,0.00006849466,0.00002785015,0.0004051525],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8089985,0.04223216,0.00379528,0.000785168,0.002186715,0.0003322284,0.0003701051,0.002437019,0.02232478,0.000638138,0.006714575,0.1091854],"study_design_scores_gemma":[0.8580851,0.1275601,0.005583269,0.00004461308,0.0006148956,0.000316088,0.0001178519,0.0009433198,0.002000253,0.0004190922,0.004279547,0.0000358524],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9855509,0.003858385,0.0005725127,0.001490272,0.0003473243,0.001491088,0.00101136,0.0001224509,0.005555859],"genre_scores_gemma":[0.9870414,0.002652483,0.00175366,0.001376889,0.0002148425,0.00138919,0.002534765,0.00004161244,0.002995151],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003544437,"threshold_uncertainty_score":0.01185739,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1722342350874766,"score_gpt":0.4218634001158832,"score_spread":0.2496291650284067,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}